NYSE:CYT Cytec Industries (CYT) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free CYT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.01 million shsAverage Volume321,456 shsMarket Capitalization$108.71 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media Get Cytec Industries alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Cytec Industries Stock (NYSE:CYT)Cytec Industries Inc. is a global specialty materials and chemicals company focused on developing, manufacturing and selling value-added products. The Company offers aerospace and industrial materials, mining and plastics industries. The Company operates through four segments: Aerospace Materials, Industrial Materials, In Process Separation, and Additive Technologies. The Aerospace Materials segment includes advanced composites, carbon fiber, and structural film adhesives. The Industrial Materials segment includes structural composite materials, which serve automotive, motorsports, recreation, tooling, and other structural materials markets and process materials, which serves aerospace, wind energy, and other process materials markets. The In Process Separation segment includes mining chemicals and phosphines. The Additive Technologies segment includes polymer additives, specialty additives, and formulated resins. The Company operates as a wholly owned subsidiary of Solvay.Read More Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. CYT Stock News HeadlinesMarch 7, 2024 | businesswire.comCyteir Announces Timeline for Voluntarily Delisting from NasdaqJanuary 12, 2024 | finance.yahoo.comLightweight Materials Market to Worth USD 348.24 Billion by 2030 | Skyquest TechnologyApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.January 7, 2024 | forbes.comSaudi Basic IndustriesDecember 20, 2023 | finance.yahoo.comGlobal Automotive Carbon Thermoplastic Market Analysis, 2023-2033November 2, 2023 | finance.yahoo.comSulfuric Acid Market Size & Share to Surpass $19.64 Billion by 2030 | Vantage Market ResearchOctober 19, 2023 | msn.comCrow Holdings Lands Its First Carteret TenantOctober 12, 2023 | finance.yahoo.comOngoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety ProfileApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.August 7, 2023 | benzinga.comAdvanced Materials in Aerospace and Defence market is projected to grow at a CAGR of 5.3% by 2033: VisiongainJuly 4, 2023 | benzinga.comMining Chemicals Market Size Predictions suggest a rise of 5.2% CAGR, to reach value of USD 17.7 Billion by 2032June 30, 2023 | finance.yahoo.comBiotech’s Drug Flop Turns Into Boon for Investors on Cash ReturnJune 30, 2023 | finance.yahoo.comCyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and DissolutionJune 22, 2023 | marketwatch.comSpecialty Chemicals Market Growth Outlook 2023 to 2030: Insights and Analysis from Market Research Report thoroughly examined with a CAGR of 8.9%June 16, 2023 | msn.comDr. Rupert Hayles Jr. named 12th president of Roberts Wesleyan UniversityJune 3, 2023 | finance.yahoo.comPreliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety ProfileMay 30, 2023 | finance.yahoo.comTechmer PM Appoints New Vice President of OperationsMay 16, 2023 | marketwatch.com2023, Glass Mat Thermoplastic Market Trends, Competitive Analysis and Forecasts to 2030May 16, 2023 | marketwatch.com2023, Prepreg Fabrics Market Trends, Competitive Analysis and Forecasts to 2030May 16, 2023 | marketwatch.com2030, Specialty Chemicals Market: Growth & StatisticsMay 16, 2023 | marketwatch.com(2023-2030)Fiber Reinforced Composites Market Share Forecast, Sales & RevenueMay 16, 2023 | marketwatch.comTypes of Applications Driving Corrosion Inhibitors Market Growth: An OverviewMay 15, 2023 | marketwatch.comDispersants Market Insights-Industry changing aspects, New Technologies and Forecast to 2031May 15, 2023 | marketwatch.comAerospace Plastics Market | 2030May 12, 2023 | marketwatch.comActivated Carbon Fiber Market Size Analysis Report 2023-2030 by Absolute Reports in Advanced Material Industry | with [111 Pages]May 11, 2023 | marketwatch.comUrethanes Coating Additives Market Research Report Analysis Untapped Industry Incremental Growth OpportunitiesMay 11, 2023 | marketwatch.comMesophase Pitch Market Report | Research Across The World 2031See More Headlines Receive CYT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cytec Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustrySpecialty Chemicals Current SymbolNYSE:CYT CUSIP23282010 CIK912513 Webwww.cytec.com Phone+1-973-3573100FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Consensus RatingSell Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-46,060,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-24.88% Return on Assets-23.83% Debt Debt-to-Equity RatioN/A Current Ratio21.89 Quick Ratio21.89 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.13 per share Price / BookN/AMiscellaneous Outstanding Shares36,000,000Free Float30,814,000Market Cap$108.71 million OptionableNot Optionable Beta0.10 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key CompetitorsOptiNoseNASDAQ:OPTNCyteir TherapeuticsNASDAQ:CYTTCartesian TherapeuticsNASDAQ:RNACImmunicNASDAQ:IMUXFibroGenNASDAQ:FGENView All CompetitorsInsiders & InstitutionsGabelli Funds LLCBought 667,412 shares on 2/13/2024Ownership: 3.083%GABELLI & Co INVESTMENT ADVISERS INC.Bought 609,800 shares on 2/13/2024Ownership: 2.850%Holdings A/S NovoSold 1,900 sharesTotal: $5,244.00 ($2.76/share)Holdings A/S NovoSold 21,100 sharesTotal: $58,025.00 ($2.75/share)Holdings A/S NovoSold 11,000 sharesTotal: $30,140.00 ($2.74/share)View All Insider TransactionsView All Institutional Transactions CYT Stock Analysis - Frequently Asked Questions Should I buy or sell Cytec Industries stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cytec Industries in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" CYT shares. View CYT analyst ratings or view top-rated stocks. What is Cytec Industries' stock price target for 2024? 1 equities research analysts have issued 1 year target prices for Cytec Industries' shares. Their CYT share price targets range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next year. View analysts price targets for CYT or view top-rated stocks among Wall Street analysts. How were Cytec Industries' earnings last quarter? Cytec Industries Inc (NYSE:CYT) issued its earnings results on Thursday, November, 11th. The specialty chemicals company reported ($0.33) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.36) by $0.03. When did Cytec Industries' stock split? Cytec Industries's stock split on the morning of Thursday, September 18th 2014. The 2-1 split was announced on Thursday, July 17th 2014. The newly issued shares were payable to shareholders after the closing bell on Wednesday, September 17th 2014. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of Cytec Industries own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cytec Industries investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Enviva (EVA), QUALCOMM (QCOM), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS). When did Cytec Industries IPO? Cytec Industries (CYT) raised $126 million in an initial public offering (IPO) on Friday, June 18th 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Wedbush PacGrow was co-manager. This page (NYSE:CYT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytec Industries Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
